Zobrazeno 1 - 9
of 9
pro vyhledávání: '"S. A. Oskolkov"'
Publikováno v:
Chernye Metally. :10-16
Publikováno v:
Nephrology (Saint-Petersburg). 26:72-76
Publikováno v:
Терапевтический архив, Vol 79, Iss 9, Pp 53-56 (2004)
Aim. To study clinicobiochemical features of chronic pyelonephritis (CPN) in the population of northen areas of the Tyumen Territory; to determine emoxipine effects on CPN treatment efficacy. Material and methods. Clinicolaboratory manifestations of
Externí odkaz:
https://doaj.org/article/77b287bc586a438a84730e83ff13713f
Publikováno v:
Medical Science And Education Of Ural. 21:16-18
Aim. To analyze nephroscintigraphy kidney functional state in patients with chronic kidney disease (CKD) on the background of chronic pyelonephritis (CRF) in combination with arterial hypertension (AH). Materials and methods. 81 patients with chronic
Publikováno v:
Medical Science And Education Of Ural. 21:73-75
Aim. To study the state of central hemodynamics measured with echocardiography in patients with chronic renal disease on the background of chronic pyelonephritis caused by nephrolithiasis and dysmetabolic nephropathy in the phase of incomplete remiss
Publikováno v:
Urologiia (Moscow, Russia : 1999). (4)
A comparative study has evaluated the effect of fluoroquinolones and beta-lactams on clinical and biochemical manifestations of chronic pyelonephritis (CPN). 108 patients aged from 18 to 59 years (mean age - 40.26 +/- 10.09 years) with secondary CPN
Autor:
N I, Kazeko, V A, Zhmurov, A A, Borovskiĭ, S A, Oskolkov, A A, Mariupol'skiĭ, M D, Dobrovol'skaia, A S, Evlochko
Publikováno v:
Urologiia (Moscow, Russia : 1999). (1)
The immunological status was studied in 335 patients with urolithiasis and pyelonephritis. The techniques used for assessment of the immunological status provided a multifactorial control over immune system function in inflammation and urolithiasis:
Publikováno v:
Terapevticheskii arkhiv. 76(9)
To study clinicobiochemical features of chronic pyelonephritis (CPN) in the population of northen areas of the Tyumen Territory; to determine emoxipine effects on CPN treatment efficacy.Clinicolaboratory manifestations of CPN were studied in 246 CPN
Publikováno v:
Urologiia (Moscow, Russia : 1999). (3)
Such HLA phenotypes as A3B35 and A9B35 occur most frequently in patients with chronic pyelonephritis (CP). In these phenotypes there are most pronounced changes in the lipid phase of red cell membranes and renal tissue. The above changes of blood cel